Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTTR
3626
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $453K | ﹤0.01% |
+161,723
| New | +$453K |
|
3627
Evolution Petroleum
EPM
$188M
| $451K | ﹤0.01% |
59,752
-302,084
| -83% | -$2.28M |
|
3628
Vanguard FTSE Emerging Markets ETF
VWO
$102B
| $451K | ﹤0.01% |
11,580
-9,990
| -46% | -$389K |
|
3629
Lesaka Technologies
LSAK
$340M
| $450K | ﹤0.01% |
+98,837
| New | +$450K |
|
3630
Nomura Holdings
NMR
$22.2B
| $450K | ﹤0.01% |
120,033
+24,133
| +25% | +$90.5K |
|
|
OPP
3631
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$205M
| $449K | ﹤0.01% |
+52,334
| New | +$449K |
|
3632
Allegiant Air
ALGT
$1.15B
| $448K | ﹤0.01% |
6,589
-2,428
| -27% | -$165K |
|
3633
National Beverage
FIZZ
$3.61B
| $448K | ﹤0.01% |
9,638
+3,787
| +65% | +$176K |
|
3634
Biglari Holdings Class B
BH
$961M
| $447K | ﹤0.01% |
3,218
-42
| -1% | -$5.83K |
|
|
TBIO
3635
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $446K | ﹤0.01% |
19,825
-465
| -2% | -$10.5K |
|
3636
Bioventus
BVS
$482M
| $445K | ﹤0.01% |
+170,597
| New | +$445K |
|
|
CURO
3637
DELISTED
CURO Group Holdings Corp.
CURO
| $445K | ﹤0.01% |
+125,442
| New | +$445K |
|
3638
Daktronics
DAKT
$1.1B
| $444K | ﹤0.01% |
157,361
-122,535
| -44% | -$346K |
|
3639
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $443K | ﹤0.01% |
50,670
-39,768
| -44% | -$348K |
|
|
LENZ
3640
LENZ Therapeutics
LENZ
$1.19B
| $443K | ﹤0.01% |
19,049
-31,047
| -62% | -$722K |
|
3641
Runway Growth Finance
RWAY
$379M
| $442K | ﹤0.01% |
38,171
-10,861
| -22% | -$126K |
|
3642
ESSA Pharma
EPIX
$9.93M
| $440K | ﹤0.01% |
174,475
-232,286
| -57% | -$586K |
|
|
QFTA
3643
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $440K | ﹤0.01% |
43,750
-401,957
| -90% | -$4.04M |
|
3644
Rush Enterprises Class B
RUSHB
$4.66B
| $437K | ﹤0.01% |
11,660
+4,947
| +74% | +$185K |
|
3645
Alliance Entertainment
AENT
$360M
| $436K | ﹤0.01% |
42,827
| – | – |
|
3646
Standex International
SXI
$2.6B
| $436K | ﹤0.01% |
4,256
-24,235
| -85% | -$2.48M |
|
3647
Citius Pharmaceuticals
CTXR
$19.9M
| $435K | ﹤0.01% |
22,045
-9,346
| -30% | -$184K |
|
3648
Verastem
VSTM
$587M
| $435K | ﹤0.01% |
90,112
-178,412
| -66% | -$861K |
|
3649
ProFrac Holding
ACDC
$675M
| $434K | ﹤0.01% |
+17,241
| New | +$434K |
|
3650
Grupo Aval
AVAL
$3.84B
| $434K | ﹤0.01% |
+171,680
| New | +$434K |
|